← Open Payments lookup

LIN CAI: Open Payments

NPI 1578932521 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,189 in 167 payments from 18 companies in 2025. Trend: 2023 $2,380 · 2024 $2,817 · 2025 $3,189

Food & beverage: $3,189
CompanyPaymentsAmount
Alkermes, Inc.30$549
Teva Pharmaceuticals USA, Inc.18$496
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$409
Janssen Pharmaceuticals, Inc15$341
ABBVIE INC.26$325
E.R. Squibb & Sons, L.L.C.11$246
Neurocrine BioSciences, Inc.15$179
Vanda Pharmaceuticals Inc.9$138
Axsome Therapeutics, Inc.4$100
Lundbeck LLC4$98

Products named: ARISTADA, UZEDY, CAPLYTA, VRAYLAR, SPRAVATO, COBENFY, INGREZZA, FANAPT.

Industry payments across TX — which companies pay providers there.